Hypercalcaemia in acromegaly is not always due to men-1

Hypercalcaemia in acromegaly is not always due to men-1

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Zabuliene, L, Tsametis, C, Karavitaki, N, Fazal-Sanderson, V, Turner, H, Wass, J
التنسيق:	Journal article
منشور في:	2005

مواد مشابهة

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
حسب: Fernandez, A, وآخرون
منشور في: (2008)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
حسب: Karavitaki, N, وآخرون
منشور في: (2008)

The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
حسب: Karavitaki, N, وآخرون
منشور في: (2009)

Acromegaly: Treatment with somatostatin analogs
حسب: Karavitaki, N, وآخرون
منشور في: (2005)

Pegvisomant: a new treatment modality for acromegaly.
حسب: Karavitaki, N, وآخرون
منشور في: (2004)

Enlarged hands and feet - Not always acromegaly
حسب: Vikrant Ghatnatti, وآخرون
منشور في: (2012-01-01)

Pegvisomant for acromegaly: does it always works?
حسب: Sebastian J. Neggers, وآخرون

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
حسب: Karavitaki, N, وآخرون
منشور في: (2005)

Hypercalcaemia due to immobility, about a case
حسب: Diego E. Sánchez-Herrera, وآخرون
منشور في: (2023-10-01)

Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.
حسب: Karuppiah, D, وآخرون
منشور في: (2014)

Acute octreotide suppression test (100 mu g sc): a valuable tool for predicting the long-term response to the long-acting somatostatin analogs in patients with active acromegaly
حسب: Karavitaki, N, وآخرون
منشور في: (2005)

Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
حسب: Ryizan Nizar, وآخرون
منشور في: (2021-09-01)

Radiation-induced hypopituitarism.
حسب: Fernandez, A, وآخرون
منشور في: (2009)

New treatments for acromegaly.
حسب: Wass, J, وآخرون
منشور في: (1998)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
حسب: Turner, H, وآخرون
منشور في: (1999)

Recent advances in the management of acromegaly [version 1; referees: 2 approved]
حسب: Georgia Ntali, وآخرون
منشور في: (2015-12-01)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
حسب: Chahal, H, وآخرون
منشور في: (2010)

Plasmapheresis-Induced Hypercalcaemia
حسب: Anas-Alwogud Abdelmogheth, وآخرون
منشور في: (2013-02-01)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
حسب: Pereira, E, وآخرون
منشور في: (2010)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
حسب: Wass, J
منشور في: (1997)

Long-term effects of radiotherapy for acromegaly.
حسب: Wass, J
منشور في: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
حسب: Wass, J
منشور في: (2003)

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
حسب: Turner, H, وآخرون
منشور في: (2004)

Symptomatic hypercalcaemia in paediatric tuberculosis
حسب: H.A. Payne, وآخرون
منشور في: (2011-03-01)

Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
حسب: Sandy Tun Min, وآخرون
منشور في: (2019-08-01)

Paraneoplastic Hypercalcaemia Associated with TCC of Bladder
حسب: A. B. Patel, وآخرون
منشور في: (2004-01-01)

Investigation protocol: acromegaly and its investigation.
حسب: Duncan, E, وآخرون
منشور في: (1999)

Hypercalcaemia Mimicking STEMI on Electrocardiography
حسب: Joseph Donovan, وآخرون
منشور في: (2010-01-01)

Vitamin D toxicity and hypercalcaemia
حسب: Pooja Singh, وآخرون
منشور في: (2021-01-01)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
حسب: Wass, J
منشور في: (2003)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
حسب: Chahal, H, وآخرون
منشور في: (2011)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
حسب: Grossman, A, وآخرون
منشور في: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
حسب: Grossman, A, وآخرون
منشور في: (1986)

Two underlying diseases causing hypercalcaemia?
حسب: Pazianas, M, وآخرون
منشور في: (2002)

A Case of Diabetes Mellitus and Hypercalcaemia
حسب: Anirban Majumder, وآخرون
منشور في: (2015-07-01)

Review: Endocrine and metabolic emergencies: hypercalcaemia
حسب: Richard Carroll, وآخرون
منشور في: (2010-12-01)

Two Different Causes of Paediatric Hypercalcaemia
حسب: Stepan Kutilek, وآخرون
منشور في: (2018-12-01)

Schimidt Syndrome: An Unusual Cause of Hypercalcaemia
حسب: Nisha Jose, وآخرون
منشور في: (2016-05-01)

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
حسب: Turner, H, وآخرون
منشور في: (1999)

Clinical MEN-1 among a large cohort of patients with acromegaly
حسب: Nachtigall, LB, وآخرون
منشور في: (2020)